Abstract
Context: Primary myelofibrosis is one of the chronic myeloproliferative disorders characterized by bone marrow fibrosis associated with extramedullary hematopoiesis and osteosclerosis. Endothelin-1 (ET1) is a potent vasoconstrictor that is also a key mediator of osteoblastic bone metastases by stimulating osteoblast proliferation and new bone formation. Case Description:Wereport laboratory, radiographic,bonedensitometry,andbonehistology data of a patient presenting with newly diagnosed, biopsy-proven myelofibrosis and osteosclerosis.We were able to demonstrate abundant ET1 signaling in the bones of our patient. Conclusions: We believe that ET1 is responsible for the osteosclerosis that develops with advanced myelofibrosis and suggest that ET1 signaling may play a role in other osteosclerotic settings as well.
Cite
CITATION STYLE
Yachoui, R., Kristianto, J., Sitwala, K., & Blank, R. D. (2015). Role of endothelin-1 in a syndrome of myelofibrosis and osteosclerosis. Journal of Clinical Endocrinology and Metabolism, 100(11), 3971–3974. https://doi.org/10.1210/jc.2015-2729
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.